Gerhard Liebisch is an expert in Biochemistry at University Hospital Regensburg (Germany). Gerhard Liebisch has authored 398 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 983 (community average: 125). How the SLR is computed.

LeadR Profile

Gerhard Liebisch University Hospital Regensburg Germany
983 ScienceLeadR Reputation 983
Network Map

Biochemistry

Subspecialties: Gastroenterology - Hepatology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1996 - 2026

Source: PubMed

University Hospital Regensburg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 398

Citations

Citations: 20 228 1st author: 15 Last author: 31 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
An adipocyte-endothelial framework linking adipose tissue inflammation to cardiometabolic vulnerability in obesity.
PMID 42845795 — cells, genes, macrophages, adipocytes, obesity, endothelial cells, weight loss, tissues, triglycerides, adipose tissue
Res Sq20260
Mild caloric restriction accelerates atherosclerosis via dysregulated cholesterol homeostasis and lipogenesis in HCHF-fed ApoE-deficient mice.
PMID 42804669 — homeostasis, cholesterol, phosphatidylcholines, weight loss, atherosclerosis, apolipoproteins e, lipidomics, esters, caloric restriction, plasma
JCI Insight20260
The insulin-like growth factor 2 mRNA-binding protein 2 affects tumor cell metabolism via mitochondrial transporter activity and lipid alterations.
PMID 42680753 — cells, genes, growth, insulin, somatomedins, neoplasms, mitochondria, rna, messenger, glutamine
Cell Death Discov20260
Critical Illness-Related Alterations in Plasma Phosphatidylcholine Species Reveal Selective Induction of PC 32:0.
PMID 42589512 — liver cirrhosis, liver, phosphatidylcholines, sepsis, critical illness, plasma
Int J Mol Sci20260
Plasma lipid alterations in thrombosis and antiphospholipid syndrome - a differentiating lipid plasma composite score.
PMID 42537907 — antiphospholipid syndrome, ceramides, thrombosis, lipidomics, sphingomyelins, plasma
J Lipid Res20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Early Phase 1 1
N/A 1

By status:

Completed 2

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map